ClinVar Miner

Submissions for variant NM_000352.4(ABCC8):c.-190C>G

gnomAD frequency: 0.00001  dbSNP: rs1395224084
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV001851771 SCV002200503 uncertain significance not provided 2021-12-19 criteria provided, single submitter clinical testing This variant occurs in a non-coding region of the ABCC8 gene. It does not change the encoded amino acid sequence of the ABCC8 protein. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with hyperinsulinism of infancy with diffuse pathology but a second variant was not observed in maternal allele (PMID: 15579781). This variant is also known as -64C>G. Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects ABCC8 function (PMID: 15579781). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV002254260 SCV002524161 uncertain significance Maturity onset diabetes mellitus in young criteria provided, single submitter research Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs1395224084) in MODY yet.
Clinical Genomics, Uppaluri K&H Personalized Medicine Clinic RCV002254261 SCV002524162 uncertain significance Transitory neonatal diabetes mellitus criteria provided, single submitter research Mutations in ABCC8 gene are associated with both neonatal diabetes mellitus as well as MODY. Patients with this mutation may have a better response to sulfonylureas. However, no sufficient evidence is found to ascertain the role of this particular variant ( rs1395224084) in neonatal diabetes yet.
OMIM RCV000009669 SCV000029887 pathogenic Hyperinsulinemic hypoglycemia, familial, 1 2004-12-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.